Google TrendCOVENTRY VS NEWCASTLE (2000+) — Premier League LIVE: Coventry City vs Newcastle United - build-up, team news, score, text commentary & match stats
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Targeting CD47-mediated c" (30 stories)

Top Headline Story

Targeting CD47-mediated cancer senescence, a novel strategy for cancer immunotherapy
Lead StoryFrontiersworld
Jun 30

Targeting CD47-mediated cancer senescence, a novel strategy for cancer immunotherapy

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQTDc3SUVYckJiZ1lCRURqZ1FXaUxMS1hSZ3VQMDhMLUxNQ0x4aTNkRUZjUVEtSlZUcTZfbmF4amFpaEtjYWo4WlpDR0NBelAwaWdMUGhvREFVNFh6M19OYWVwVmdfa3RTYUd2ZHMzWktLbEhQNXhhV3RYRzkweWxjTVpPT1pxTnRIUHdYampJbTQ1Zw?oc=5" target="_blank">Targeting CD47-mediated cancer senescence, a novel strategy for cancer immunotherapy</a>  <font color="#6f6f6f">Frontiers</font>

Real-time search volume
2000+18m ago

coventry vs newcastle

Premier League LIVE: Coventry City vs Newcastle United - build-up, team news, score, text commentary & match stats

2000+18m ago

levante - sevilla

Levante - Sevilla en directo

1000+18m ago

servicio de control de inmigración y aduanas

"La cosa se está poniendo tensa": manifestantes se enfrentan a agentes migratorios en Oregon

200+18m ago

indigo girls

Indigo Girls cancel show after tour bus driver dies in highway crash

Search Results for "Targeting CD47-mediated c"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Targeting hypoxic exosomal IGFBP2 overcomes CD47-mediated immune evasion in glioblastoma
Natureworld

Targeting hypoxic exosomal IGFBP2 overcomes CD47-mediated immune evasion in glioblastoma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9HYnp6MHZCQUFmY3Ryc0JXZl9GMy13aVQ0eVFicnZLejhuOVJZT0QyUWFNdDVuTHN4ZjZmY002ZDJGX0pCa3A3eU1KWkxFSmtkNFlEWHJCXzRtLWRySVc0?oc=5" target="_blank">Targeting hypoxic exosomal IGFBP2 overcomes CD47-mediated immune evasion in glioblastoma</a>  <font color="#6f6f6f">Nature</font>

CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination
PNASgeneral

CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE8yZXVSd3JDaE9ZZnZHS2NXQkRHRFNScWNkWmpRc3FmWkJDVWtRNWppZEk4d0U4YkRhS0lhTTRrd0hFb3pSb1RxVXZSZmlLbng3WjZyWTItSkptanpH?oc=5" target="_blank">CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination</a>  <font color="#6f6f6f">PNAS</font>

CD47 as a prognostic biomarker and potential immunotherapy target in penile squamous cell carcinoma
Natureworld

CD47 as a prognostic biomarker and potential immunotherapy target in penile squamous cell carcinoma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE8tYW1ya1BaZWZPQkw1ZTJiSThGWFh2ZjN3Q3g1ZDZPWlNNYjl1YjVQRTB5Q2FGTHJoVmo1Y1ZFMXVrZjE0OWV1S2xuRFQwblFYY0tOdXBIaXF3Q2xXVFhV?oc=5" target="_blank">CD47 as a prognostic biomarker and potential immunotherapy target in penile squamous cell carcinoma</a>  <font color="#6f6f6f">Nature</font>

Targeted Delivery of miR-34a via Anti-CD47 Antibody Conjugates for Enhanced Cancer Immunotherapy in Triple Negative Breast Cancer
Wiley Online Libraryworld

Targeted Delivery of miR-34a via Anti-CD47 Antibody Conjugates for Enhanced Cancer Immunotherapy in Triple Negative Breast Cancer

<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTFBYbnYyalFMNTRBWDR4MkNfd1c1VWRvUWRjcnAzdlA5ZGJlTmJCV2M5ekxxWjhwZ0VRQWstOS1YNUJtLXpGQ1RDb3N0OFlCODM1d3ByQUt3aDZhT2kyRlpBRDlwN1pYbEZaZUNHMmtlSWI?oc=5" target="_blank">Targeted Delivery of miR-34a via Anti-CD47 Antibody Conjugates for Enhanced Cancer Immunotherapy in Triple Negative Breast Cancer</a>  <font color="#6f6f6f">Wiley Online Library</font>

CD47-mediated regulation of glucose and lipid metabolism: implications for the pathogenesis of MASLD
Frontiersgeneral

CD47-mediated regulation of glucose and lipid metabolism: implications for the pathogenesis of MASLD

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQNVFIeWdVR2VpWWRHMzdwWWhHN1JBUGxrREpqOU8xNlFGVXcyYXkwdU9QdmoyTWlENjBCa0JaazRIblZYSTRMY3VqYkZoOE42TVo0cnlwYTNERW96aTU2bFJhQTlnZU52UnVWaDVsS01GRWFBb2VzYTZvUzEwdzUxWUwtUlZQRTRhSzYzZGRqNEREM3djREE?oc=5" target="_blank">CD47-mediated regulation of glucose and lipid metabolism: implications for the pathogenesis of MASLD</a>  <font color="#6f6f6f">Frontiers</font>

Repurposing Cardiac Glycosides to Potentiate CD47 Blockade through Calreticulin-mediated Phagocytic Effects for Lung Cancer Treatment
Wiley & Sonsworld

Repurposing Cardiac Glycosides to Potentiate CD47 Blockade through Calreticulin-mediated Phagocytic Effects for Lung Cancer Treatment

<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTE03bVpydUVzZlBjU3A3R2oybGV1TV9FX0NxX1RWemRBX3pJVzNaWUJ2R0VOSEFTM0trY1VHempOLWdKVmJKSHhEblFGVlEwNjVhVENjUnVxWnFzd0lmWldQdG43VEF1emNkU1RQenVRaUtXMFRNc1NYellDd1U?oc=5" target="_blank">Repurposing Cardiac Glycosides to Potentiate CD47 Blockade through Calreticulin-mediated Phagocytic Effects for Lung Cancer Treatment</a>  <font color="#6f6f6f">Wiley & Sons</font>

Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion
Natureworld

Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB2WGNpXzA1Sm1vZHNwZDQ4clM1UENYOVQtZ1h1N3cxN29OVWRCeFRqQ2kwanFDSU5MMm8xX0NFMER4b0U4NnhqbWlyWkdEQ2dBVXZQVDdvYTZoSG5DaHRF?oc=5" target="_blank">Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion</a>  <font color="#6f6f6f">Nature</font>

Targeting CD47 as a Novel Immunotherapy for Breast Cancer
Frontiersworld

Targeting CD47 as a Novel Immunotherapy for Breast Cancer

<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxOcEdDWFNGYmZXemVZVWc4blcxYVFad0RYdmNTeVprQ1pfd3VOaXVFRUY5OXIyM3FkNUk2TzBCajU4SFBlUC1sbEFFNkY5cXR1RjNrZHZ6MnhISTI4S29fYlhTWDlBcEV0a0Y1YTBvenFldEU5RjFsMTBQVHV6MkhPQTg4TWUtek5KT0hxZg?oc=5" target="_blank">Targeting CD47 as a Novel Immunotherapy for Breast Cancer</a>  <font color="#6f6f6f">Frontiers</font>

Catechin suppresses HNSC via STXBP1 dependent inhibition of macrophage infiltration and CD47 mediated immune evasion
Naturetech

Catechin suppresses HNSC via STXBP1 dependent inhibition of macrophage infiltration and CD47 mediated immune evasion

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0yN3Vtb1NmRTNSRWpST2k2V3FwODBhWlItbkRTSmFNb0E3SHZReXlxNmNoaEhvUXpUeHpNRW5oMWpZM0JrQ1FuRUlTWEc5YnZsbW4xTTVDMUxwX0FxVXln?oc=5" target="_blank">Catechin suppresses HNSC via STXBP1 dependent inhibition of macrophage infiltration and CD47 mediated immune evasion</a>  <font color="#6f6f6f">Nature</font>

CD47 as a promising therapeutic target in oncology
Frontiersgeneral

CD47 as a promising therapeutic target in oncology

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxNX2NDa1dSZ0tLR1FPQ1NvUHNLZ0dJcEJnelc0cFRtZHFfN2ZsSFYxREo1SXdqSEdqVzlIUzVFUUV1aF9vVjF6bUZmWXRwQzd3NWVVTXg2ZlhHRGdubE43TzJMcXM1R0RBY295b20wYm55b29PMExNdWdXM1dsRVlkalozMUFtMEkxMngxbFhMLW0?oc=5" target="_blank">CD47 as a promising therapeutic target in oncology</a>  <font color="#6f6f6f">Frontiers</font>

Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis
Naturegeneral

Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE8tUVhOLVZnNHZNN0RTZmswOTBkWEFuX3FSWEZEX3lMbVcwQTc1ZGNmLXo3WXZ1VUxoUTlnenBqSGc3UkpCZ2JkaEQ5amZmekRQTHJDZEtPNjlJcy1QUkZF?oc=5" target="_blank">Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis</a>  <font color="#6f6f6f">Nature</font>

Engineered CD47 protects T cells for enhanced antitumour immunity
Natureworld

Engineered CD47 protects T cells for enhanced antitumour immunity

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5DRGQ2cnRtTUxqSlNkQ3h1MFVIcmlrV3dBb3Z6WUJiY1VmZ1IwVlZxZGxxQ2lNZ0VpSm8zX2U0bFV0Tm8tNExuQVlGeGRLZGs3V3lOOWpQY09IZFVQX21v?oc=5" target="_blank">Engineered CD47 protects T cells for enhanced antitumour immunity</a>  <font color="#6f6f6f">Nature</font>

Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion
Natureworld

Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE42RzVOZjJyVXJFUFRYaDBocnZVQTVoUk5GWXd3Zk5KaFVkQUpfREJ3bzQwNThyZ1JUVmFLNW5MY2o4VjRIdDRJMUU3dGRTa1EwZnhtNG9ycEhuS1lYclFz?oc=5" target="_blank">Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion</a>  <font color="#6f6f6f">Nature</font>

Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition
Naturegeneral

Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5NZTRyQ29wRFg3XzFwOWZ2Rm5TSElWaklfZmVRbkNEaExuLUgtRjVuazcyQmc0ZWkwX2lzX2lLbUN4UTRaWkVhd1EySGF0MFRtXy1waVRIb21ybkt0MjZj?oc=5" target="_blank">Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition</a>  <font color="#6f6f6f">Nature</font>

Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
Natureworld

Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1kVFlHa2p1eS1qUXdfRUtZOHAzWS1jclRvaXgwanVfckZtU3EzLWc4akVqNW5vNUhYcDZBSjZ4c1BtZDFDNDR1VHVrR0xHR0M3QnJ4VF9DMU1lWEQ4cWtF?oc=5" target="_blank">Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches</a>  <font color="#6f6f6f">Nature</font>

An in-situ peptide-antibody self-assembly to block CD47 and CD24 signaling enhances macrophage-mediated phagocytosis and anti-tumor immune responses
Natureworld

An in-situ peptide-antibody self-assembly to block CD47 and CD24 signaling enhances macrophage-mediated phagocytosis and anti-tumor immune responses

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1jNWdneGZQX3hlZzRMLXJNZ1hlSVFqSy1LMzZ2aEw1azFobUdkTEFOZFZiUDlZMGNQQ0JlcnpkM1R5aU5TY2VLTmZsa3BkaF9kenhMY2VackMtVGtXZS1v?oc=5" target="_blank">An in-situ peptide-antibody self-assembly to block CD47 and CD24 signaling enhances macrophage-mediated phagocytosis and anti-tumor immune responses</a>  <font color="#6f6f6f">Nature</font>

USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity
Naturetech

USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB6dDB2Q0VlalEzeURzRVlfZ2Z0cHFzT1dQdXdQdmxER3NFcFdmS3lGRzJoZXdzYlRDRk1SNE00eFlISkNfY2VaWmdIUkNQa3pQU3dadzNaZVJLMGxlaUZR?oc=5" target="_blank">USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity</a>  <font color="#6f6f6f">Nature</font>

High-throughput engineering of bispecific antibodies to enhance macrophage-mediated cytotoxicity of B-cell lymphoma
Naturegeneral

High-throughput engineering of bispecific antibodies to enhance macrophage-mediated cytotoxicity of B-cell lymphoma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBEV3pObGRJSkdtZDNESTRwTUNZbzVZdzQ2RjNjdW16dFdjNjJqRGhhcFRjMWtTb1Eta0dXV3RXang3NUJiclVKZUVOTEFJeUZIX0VGeXNUSDIwcEVXaWNV?oc=5" target="_blank">High-throughput engineering of bispecific antibodies to enhance macrophage-mediated cytotoxicity of B-cell lymphoma</a>  <font color="#6f6f6f">Nature</font>

Role of CD47 in tumor immunity: a potential target for combination therapy
Natureworld

Role of CD47 in tumor immunity: a potential target for combination therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBOTzhUV0EtRHN6djJhSVlXQTRwUGVpVU1NTXZDeWQ1VHRlc19RQW15d0RHdVVmQnNTX0QyYUdzdGZwRUY2TGRRUjduOEcxc1lFaHJQdTJuSFV3YklJd0M4?oc=5" target="_blank">Role of CD47 in tumor immunity: a potential target for combination therapy</a>  <font color="#6f6f6f">Nature</font>

Phagocytosis-initiated tumor hybrid cells acquire a c-Myc-mediated quasi-polarization state for immunoevasion and distant dissemination
Natureworld

Phagocytosis-initiated tumor hybrid cells acquire a c-Myc-mediated quasi-polarization state for immunoevasion and distant dissemination

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE83eGpQTWQwUWV2Wl9KQjNwN0NlZ1RoVFZKMi1iN1AwaXFlcEdEb1V6QW11OFEtVEZIbTIxdnBVNkV5WnBNSXhBR3U2cDQzQmtaX3JVMlFpZVM2NjlybURn?oc=5" target="_blank">Phagocytosis-initiated tumor hybrid cells acquire a c-Myc-mediated quasi-polarization state for immunoevasion and distant dissemination</a>  <font color="#6f6f6f">Nature</font>

CD47 inhibits phagocytosis through Vav dephosphorylation
Rockefeller University Pressgeneral

CD47 inhibits phagocytosis through Vav dephosphorylation

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxOcHdfUFh1RGpBazhoYTBLbUlIX0NnRDlFUjQ5dnBtRVhDbWo0UXkyMWxDZXNHNGJWU0drcUNzcWxtRlpZMzZWSFZfNWFyZjVJbUVFLXliNTJuZ0hkVlhLSy1hUDFtcTRnWHNhSGRYOHNOdUwzRDhfZjdLRlhsclVtbUdFeVhvMGFfLXp0dHdGSG1ZZGYwZGQ2aE4ySQ?oc=5" target="_blank">CD47 inhibits phagocytosis through Vav dephosphorylation</a>  <font color="#6f6f6f">Rockefeller University Press</font>

Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect
Naturegeneral

Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9aX1JPSndSZFY3WUp4Y21jaHJGNEFIVGtldHFreWtZRDVGS2Q2d19uR0J3dFpoUnZ3M0g4MTY1Mm1jdXc0OGFMRTJVTGNtcnZxb3EyN18xVTBqS18xNnNZ?oc=5" target="_blank">Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect</a>  <font color="#6f6f6f">Nature</font>

Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma
Naturegeneral

Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBqclRkekxNSHBuSF93cU5jUzZiZHZWaXlZd2twOUNQUjlHVklERy1OV1g2eng0QkRRdHhhQ1dxTzRGcVoxV3pSOWFsR1NfMFVtSDFqWFB2UDF1ZktlNmZF?oc=5" target="_blank">Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma</a>  <font color="#6f6f6f">Nature</font>

Opportunities and challenges for anti-CD47 antibodies in hematological malignancies
Frontiersworld

Opportunities and challenges for anti-CD47 antibodies in hematological malignancies

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOc3JYVWM4Vnhtd19WeTA3VktmcXAyYkR3M1dIRWd3QXo2QkRsV0xHZnZQOEFBdU5QS2lQRU12NDB0OXZEd1BZU3lXU3d5Ymx6YmZPSUJHeGV1ZmxueVQxNWYtQl9ibmEwQnN3U1ZadDk5WXVNRmpzQnc1b1FLOE5hNXh2Z2ZrQ0lOeTZEbjhCcmZGdw?oc=5" target="_blank">Opportunities and challenges for anti-CD47 antibodies in hematological malignancies</a>  <font color="#6f6f6f">Frontiers</font>

Silencing of SIRPα enhances the antitumor efficacy of CAR-M in solid tumors
Naturegeneral

Silencing of SIRPα enhances the antitumor efficacy of CAR-M in solid tumors

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1HRU1IOTNIdEs2LXlUaXRnanozX01mMUJVZ2ZsY05UbWd5eU1WbG1ZQm9lQ25KVHJORWVuYmtRdTR5NW1icTJtSzloQzBEV1QzRHZDQW9rYjVBQ2JOOWRF?oc=5" target="_blank">Silencing of SIRPα enhances the antitumor efficacy of CAR-M in solid tumors</a>  <font color="#6f6f6f">Nature</font>

Structural–functional diversity of CD47 proteoforms
Frontiersworld

Structural–functional diversity of CD47 proteoforms

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQeUpNY21SRGM5Y0pTNXgwV3dCaXJwMWhaQ1Q3ZElqUndDbmloelBRSDZuaElXVFA3WDlQTlZ4elY0Zko3cWxZS1pEYWVsLVJCOFVkZTV0cnRqLVJwcjZOMFYtSnZGZHlwR0JrU1lZbkVfN1ZtX2hMeEJDLV9XcDFjVmNVVy1kdlMwZDdyOEpnZlh5UQ?oc=5" target="_blank">Structural–functional diversity of CD47 proteoforms</a>  <font color="#6f6f6f">Frontiers</font>

Airway epithelial CD47 plays a critical role in inducing influenza virus-mediated bacterial super-infection
Naturetech

Airway epithelial CD47 plays a critical role in inducing influenza virus-mediated bacterial super-infection

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBLeXJCMWhGaERKRWtwNnlZSjREYXM0NWhwdUMyQXl5NFRwR285MHBCT05tNEJiSVJDLVVxSEpEN1o1T2VhVFF5UGNpUkhQMDl5bEtseno5UFBjdW9kNEl3?oc=5" target="_blank">Airway epithelial CD47 plays a critical role in inducing influenza virus-mediated bacterial super-infection</a>  <font color="#6f6f6f">Nature</font>

IL-21 promotes the anti-tumor effect of anti-CD47 chimeric antigen receptor macrophages in ovarian cancer
Naturegeneral

IL-21 promotes the anti-tumor effect of anti-CD47 chimeric antigen receptor macrophages in ovarian cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9rWTlLYWtuaHVEd0pidlBDTVdSYTFRR292dXVKQ05aYmZjemNSV1FmQVFVTURtNGlnNFE4b3VpTzlraXBoYUpGR3FaVHV0dHJnSmhVemNOeTFGbnNidW9n?oc=5" target="_blank">IL-21 promotes the anti-tumor effect of anti-CD47 chimeric antigen receptor macrophages in ovarian cancer</a>  <font color="#6f6f6f">Nature</font>

CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
Rockefeller University Pressgeneral

CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNaW1faGVOd2lhOGFBQjBybGNvbFF4RXBVWW1YUno4V28wREFTMlZPS3ZoNDhvcXFadXJPNHBiUmNmMllPcTNTZXBocktCUVhacHBxUk9xTHpvSnh0c0RGLU14cm02cV93QXB0aFp1Q2JhTmhLUmtjSUJPckVFT25RbkVZQmhRWkFlNmhlazNxZGhvNUc4SjNsN2N3?oc=5" target="_blank">CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes</a>  <font color="#6f6f6f">Rockefeller University Press</font>

"Targeting CD47-mediated c" — Live Google News Trends & Headlines